Noxopharm (ASX:NOX): Interview with CEO Graham Kelly

August 19, 2020

NOX, Noxopharm, video

We talked with Graham Kelly about Noxopharm’s clinical success with Veyonda and in particular its synergies with radiation therapy. Veyonda is a drug that seems to work in a wide variety of cancers.